GSGiulia Spaltro

Giulia Spaltro

*This is an algorithmically generated author record based on publicly available information.

Giulia Spaltro has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Semaglutide and Tirzepatide in a Remote Weight Management Program: Retrospective 12-Month Outcomes in Program Completers (Preprint)

    by Becky Richards, Will Lunt, Michael Whitman, Giulia Spaltro, Rachel Hall

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Obesity affects over 890 million adults worldwide and traditional lifestyle interventions often lack long-term success. While GLP-1 receptor agonists have shown strong weight loss outcomes, access to specialist care is limited by cost and capacity. Objective: This study evaluated the effectiveness, feasibility, acceptability, and potential cost-effectiveness of a 12-month remote GLP-1RA-supported weight management program, comparing outcomes between tirzepatide and semaglutide. Methods: This retrospective analysis included 339 participants (82% women) who completed a 12-month remote weight management program with either tirzepatide (n=209) or semaglutide (n=130) between February and June 2024. The program combined medication, app-based behavioral support, coaching from registered dietitians/nutritionists, and clinical oversight. It featured five phases with evidence-based behavior change techniques, monthly monitoring, and safety protocols. Primary outcomes were mean weight change and proportions achieving ≥10% and ≥15% weight loss. Secondary outcomes included behavioral changes, side effects, acceptability, feasibility, and estimated cost-effectiveness compared to NHS care. Results: Mean weight change at 12 months was -22.9 kg (-22.1% of baseline weight, SD=8.0, P<0.05) in the tirzepatide cohort and -18.1 kg (-17.1% of baseline weight, SD=8.1, P<0.05) in the semaglutide cohort. Achievement of ≥10% weight loss occurred in 95.2% of tirzepatide participants and 83.1% of semaglutide participants, while ≥15% weight loss was achieved by 83.7% and 56.2%, respectively. The proportion of inactive participants (no weekly exercise) decreased substantially in both cohorts (tirzepatide: 14.8% to 6.7%; semaglutide: 22.3% to 5.4%, P<0.05). Side effects decreased significantly over the 12-month period, with participants reporting no side effects increasing from 41.6% to 60.3% (tirzepatide) and from 53.8% to 67.7% (semaglutide), while common initial side effects including constipation, nausea, and fatigue showed significant reductions (p < 0.05). Economic modelling suggested a 60-70% cost saving compared to specialist weight management services and a 10-60% cost saving compared to primary care services in the NHS. Conclusions: This real-world evaluation demonstrates that remotely delivered, GLP-1RA-supported weight management programs can achieve weight loss outcomes that align closely with clinical trial results while potentially reducing healthcare costs by 10-70% compared to traditional UK services. Both tirzepatide and semaglutide cohorts exceeded clinically significant weight loss thresholds with acceptable safety profiles and positive behavioural changes. These findings support the feasibility and effectiveness of digital delivery models for expanding access to specialist obesity treatment within resource-constrained healthcare systems, with outcomes that compare favourably to pharmacological intervention alone.


  • Open Access

    A remotely-delivered weight management service to support existing obesity services in the UK National Health Service: Preliminary findings from an early-stage service evaluation (Preprint)

    by Giulia Spaltro, Michael Whitman, Rebecca Richards

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Specialist weight management services (SWMS) in the UK National Health Service (NHS) are faced with long waiting lists and limited resources. Remotely-delivered SWMSs have the potential to support existing NHS services to increase access to treatment for patients living with obesity, however evidence of remotely-delivered services working to support NHS SWMSs in practice remains limited. Objective: This service evaluation explored the potential effectiveness, feasibility and acceptability of Second Nature’s remotely-delivered SWMS for adults living with obesity referred from existing NHS SWMSs. Preliminary findings from the first phase (‘Preparing for weight loss’) of a three-phase remotely-delivered SWMS are presented. Methods: Participants were referred to Second Nature by NHS SWMS leads. Eligible participants were assessed by a multidisciplinary team and allocated to one of three 16-week interventions: 1) a psychologically informed app-based program, 2) a Dialectical behavioral Therapy (DBT)-based skills training group program and 3) one-to-one psychological support. Primary outcomes were weight change (kg) and percentage weight change following completion of the intervention. Secondary outcomes included psychological distress, emotional eating, health-related quality of life, physical activity, emotion regulation, intervention feasibility and acceptability. Results: At 16-weeks, there were significant differences in weight (p=.012), with an average weight change of -2.2kg (SD 5.16) (-1.6% body weight). Participants in the app-based program lost the most weight (-2.8kg), and participants in the one-to-one psychological support program lost the least weight (-1.3kg). Psychological distress reduced to below the clinical threshold (mean score 0.95, SD 0.62) (p<.001). Emotional eating behaviors and difficulties in emotion regulation also decreased (p=.027 and p<.001). Health-related quality of life saw improvements in self-care, usual activities and anxiety/depression (p=.044; p=.014; p=.029), while participants’ challenges with mobility and pain/discomfort remained unaffected (p>.05). Subjective ratings of health status improved by 17.4% (p=.003). There were no significant changes in physical activity levels (p=.264), with most participants remaining ‘Inactive’ or ‘Moderately inactive’. Engagement with intervention sessions was high (93.7%) and attrition rate was 27.4%. Participants rated their satisfaction with the program at 9/10, while also providing insightful suggestions for future service improvement, such as improved app-functionality and more accessible physical activity support. Conclusions: This preliminary service evaluation suggests that a remotely delivered SWMS has the potential to be effective, feasible and acceptable for NHS-referred patients in the UK. A full evaluation of all three phases of this service with a larger sample size is required to support these early findings.


  • Open Access

    The potential of a remotely-delivered weight management service to support existing specialist weight management services in the UK National Health Service: Preliminary findings from a pilot service evaluation (Preprint)

    by Giulia Spaltro, Michael Whitman, Rebecca Richards

    BACKGROUND Specialist weight management services (SWMS) in the UK National Health Service (NHS) are faced with long waiting lists and limited resources. Remotely-delivered SWMSs have the potential to support existing NHS services to increase access to treatment for patients living with obesity, however evidence of remotely-delivered services working to support NHS SWMSs in practice remains limited. OBJECTIVE This service evaluation explored the potential effectiveness, feasibility and acceptability of Second Nature’s remotely-delivered SWMS for adults living with obesity referred from existing NHS SWMSs. Preliminary findings from the first phase (‘Preparing for weight loss’) of a three-phase remotely-delivered SWMS are presented. METHODS Participants were referred to Second Nature by NHS SWMS leads. Eligible participants were assessed by a multidisciplinary team and allocated to one of three 16-week interventions: 1) a psychologically informed app-based program, 2) a Dialectical behavioral Therapy (DBT)-based skills training group program and 3) one-to-one psychological support. Primary outcomes were weight change (kg) and percentage weight change following completion of the intervention. Secondary outcomes included psychological distress, emotional eating, health-related quality of life, physical activity, emotion regulation, intervention feasibility and acceptability. RESULTS At 16-weeks, there were significant differences in weight (p=.012), with an average weight change of -2.2kg (SD 5.16) (-1.6% body weight). Participants in the app-based program lost the most weight (-2.8kg), and participants in the one-to-one psychological support program lost the least weight (-1.3kg). Psychological distress reduced to below the clinical threshold (mean score 0.95, SD 0.62) (p<.001). Emotional eating behaviors and difficulties in emotion regulation also decreased (p=.027 and p<.001). Health-related quality of life saw improvements in self-care, usual activities and anxiety/depression (p=.044; p=.014; p=.029), while participants’ challenges with mobility and pain/discomfort remained unaffected (p>.05). Subjective ratings of health status improved by 17.4% (p=.003). There were no significant changes in physical activity levels (p=.264), with most participants remaining ‘Inactive’ or ‘Moderately inactive’. Engagement with intervention sessions was high (93.7%) and attrition rate was 27.4%. Participants rated their satisfaction with the program at 9/10, while also providing insightful suggestions for future service improvement, such as improved app-functionality and more accessible physical activity support. CONCLUSIONS This preliminary service evaluation suggests that a remotely delivered SWMS has the potential to be effective, feasible and acceptable for NHS-referred patients in the UK. A full evaluation of all three phases of this service with a larger sample size is required to support these early findings.